Skip to main content
Case Reports in Urology logoLink to Case Reports in Urology
. 2019 Nov 20;2019:5734970. doi: 10.1155/2019/5734970

Corrigendum to “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy”

Abhishek Bhat 1,, Bruno Nahar 1, Vivek Venkatramani 1, Indraneel Banerjee 1, Oleksandr N Kryvenko 1,2,3, Dipen J Parekh 1,3
PMCID: PMC6886331  PMID: 31827970

In the article titled “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy” [1], the last sentence in the Abstract should be corrected from “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with Pazopanib followed by Nivolumab and Adalimumab followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response” to “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with neoadjuvant targeted therapy followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response”.

References

  • 1.Bhat A., Nahar B., Venkatramani V., Banerjee I., Kryvenko O. N., Parekh D. J. Metastatic renal cell carcinoma with level IV thrombus: contemporary management with complete response to neoadjuvant targeted therapy. Case Reports in Urology. 2019;2019:5. doi: 10.1155/2019/7102504.7102504 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Case Reports in Urology are provided here courtesy of Wiley

RESOURCES